Tag Archives: MRI

Further Dementia Diagnostic Test Accuracy Systematic Review Protocols (Cochrane Database)

Posted on August 29, 2014 by Dementia and Elderly Care News

Summary This is an additional list of diagnostic testing-related protocols, further to the Cochrane Dementia and Cognitive Improvement Group (CDCIG) Diagnostic Test Accuracy (DTA) protocols and protocol templates listed earlier in Generic Protocol(s) for Diagnostic Test Accuracy Reviews in Dementia … Continue reading →

Appropriate Use of Neuroimaging in Dementia Diagnosis (Ontario Health Technology Assessment Series / BBC News)

Posted on April 4, 2014 by Dementia and Elderly Care News

Summary This economic literature review and cost-effectiveness analysis investigated neuroimaging for diagnostic purposes, and in particular examined whether computed tomography (CT) or magnetic resonance imaging (MRI) should be used. It was not possible to answer the specific research questions with … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Researchers (mostly), In the News, International, Systematic Reviews | Tagged BBC Health News, Benign Primary Brain Tumour, Brain Imaging, Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCC), Centre for Imaging Science: Hammersmith Hospital, CT Brain Imaging, CT Versus MRI, Diagnostic Imaging, Electroencephalography (EEG), Imaging, Imaging Services, Magnetic Resonance Imaging (MRI), Malignant Primary Brain Tumour, Meningiomas, MRI, MRI Scans, Neuro-Technology Patents, Neuroimaging, Neuroimaging in Dementia Diagnosis, Neuroimaging of Dementia, Neuroimaging Tools, NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer Disease and Related Disorders Association, Ontario Health Technology Assessment Series, Positron Emission Tomography (PET), SharpBrains, Single-Photon Emission Computed Tomography (SPECT or Less Commonly SPET), Subdural Hematoma (SDH), THETA: Toronto Health Economics and Technology Assessment | Leave a comment

Cognitive and Neuroimaging Predictors of Progression from Mild Cognitive Impairment to Dementia (NHS Choices / Journal of Alzheimer’s Disease)

Posted on December 27, 2013 by Dementia and Elderly Care News

Summary The detection of pre-clinical Alzheimer’s Disease appears to be accomplished best by the use of a combination of information, taken from targeted neuroimaging and complementary neuropsychological assessments of cognitive functioning. This combination of approaches may be necessary in order to … Continue reading →

Posted in Acute Hospitals, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Patient Care Pathway, Quick Insights, Universal Interest | Tagged 1Institut Universitaire de Gériatrie de Montréal, Behind the Headlines, Canada, Canadian Institutes of Health Research, Canadian Institutes of Health Research (CIHR), Cortical Thickness, Cortical Thinning, Critical Appraisals, Detection of Incipient Dementia, Heart and Stroke Foundation of Canada, Hippocampal Volume, Institut Universitaire de Gériatrie de Montréal, Journal of Alzheimer's Disease, Magnetic Resonance Imaging (MRI), MCI: Mild Cognitive Impairment, Middle Frontal Gyri, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Montréal, MRI, MRI Brain Imaging, MRI Scans, Neuroimaging, Neuropsychological Measures, Progression of Mild Cognitive Impairment to Dementia, Right Anterior Cingulate, Transition from Cognitive Impairment to Dementia, Université de Montréal, White Matter Hyperintensities | Leave a comment

Data Linkage and Extract Service: Hospital Episode Statistics and the Diagnostic Imaging Dataset (HSCIC)

Posted on September 9, 2013 by Dementia and Elderly Care News

Summary Hospital Episode Statistics (HES) contains roughly 1 billion records on patients attending accident and emergency units, whether admitted for treatment or attending outpatient clinics. The Diagnostic Imaging Dataset (DID) is a collection of data from NHS-funded diagnostic imaging tests … Continue reading →

Posted in Acute Hospitals, For Doctors (mostly), For Researchers (mostly), National, NHS, Quick Insights, UK, Universal Interest | Tagged Administrative Data Sets, Admitted Patient Care Commissioning Data Sets, Aggregate Data, Anonymised Patient Medical Records, Applied Radiology, Bespoke Data Linkages, Bespoke Record-Level Extracts, Brain Imaging, Cancer Data from the Office for National Statistics, Central Return Data Sets, Clinical Data Sets, Clinical Data Standards Network (CDSN), Clinical Data Standards Network Group, Clinical Practice Research Datalink (CPRD), Commissioning Data Sets, Data Linkage and Extract Service, Data Quality, Data Standards, De-Identified Data, Derivation of Patient Classification Code, Diagnostic Imaging, Diagnostic Imaging Dataset (DID), DID, Electronic Database of NHS Patient Demographics, English NHS Observational Data and Interventional Research Service, Functional Brain Imaging, General Practice Extraction Service (GPES), Health and Social Care Information Centre, Health and Social Care Information Centre (HSCIC), HES, Hospital Episode Statistics, Hospital Episode Statistics (HES), Hospital Episode Statistics Linked to Mental Health Minimum Data Set, Hospital Episode Statistics Linked to Mortality Data from the Office for National Statistics, Hospital Episode Statistics Linked to Patient Reported Outcome Measures, Hospital Episode Statistics Linked to the Diagnostic Imaging Dataset, Infostandards.org Website (HSCIC), Linkage of HES to DID, Linked Data Sets, Magnetic Resonance Imaging (MRI), Medication Messages (UK SNOMED CT), Mental Health Minimum Data Set (MHMDS), Mortality Data from the Office for National Statistics, MRI, MRI Scans, Neuroimaging, NHS Data Model and Dictionary, NHS Data Model and Dictionary Service (NHS DMDS), NHS Dictionary of Medicines and Devices (dm+d), NHS Health and Social Care Information Centre, NHS Registration Data from the Personal Demographics Service, ONS Mortality Data, Open Data, Patient Classification Code, Patient Reported Outcome Measures (PROMs), Patient Status and Tracking Data, Payment by Results (PbR), Personal Confidential Data, Personal Demographics Service (PDS), Primary Care Data, Professional Records Standards in Health and Social Care, PROMS, Pseudonymisation, Pseudonymised Data, Radiological Information Systems, Records Standards in Health and Social Care, Secondary Uses Service (SUS PbR), Secondary Uses Service Payment by Results, SUS Payment by Results (PbR), Transparency and Open Data | Leave a comment

Frontotemporal Dementia (BMJ)

Posted on August 13, 2013 by Dementia and Elderly Care News

Summary Frontotemporal dementia involves a diverse range of conditions which are a cause of young onset dementia. There is selective brain atrophy in the frontal and temporal lobes, which requires brain magnetic resonance imaging for accurate diagnosis. Approximately one-quarter of … Continue reading →

Posted in Acute Hospitals, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Mental Health, Quick Insights, Universal Interest | Tagged Arnold Pick, Association for Frontotemporal Degeneration, Behavioural Variant Frontotemporal Dementia (bvFTD), BMJ, Brain Imaging, C9ORF72 Gene, Corticobasal Syndrome (CBS), Dementia Research Centre: UCL Institute of Neurology, Dementia Research Centre: University College London, Frontotemporal Dementia, Frontotemporal Dementia (FTD), Frontotemporal Dementia Support Group, Frontotemporal Dementia With Motor Neurone Disease (FTD-MND), Frontotemporal Lobar Degeneration, Frontotemporal Lobar Dementia (FTD), FUS Protein, Fused in Sarcoma (FUS) Protein, Genetic Profiling, Logopenic Aphasia, Magnetic Resonance Imaging (MRI), Microtubule Associated Protein Tau (MAPT), MRI, MRI Scans, Neurodegeneration, Neurodegenerative Diseases, Neuroimaging, Neurological Disease, Neurology, Pick’s Disease, Progressive Non-Fluent Aphasia (PNFA), Progressive Nonfluent Aphasia, Semantic Dementia, TDP-43, TDP-43 Pathology, Trazodone, UCL Institute of Neurology: University College London, University College London, Valosin Containing Protein (VCP), Young Onset Dementia (YOD) | Leave a comment

NeuroAD™ for Mild and Moderate Alzheimer’s Disease (NIHR)

Posted on June 19, 2013 by Dementia and Elderly Care News

Summary This briefing from the NIHR Horizon Scanning Centre outlines the principles and purpose of the NeuroAD™ system, from Neuronix. NeuroAD™ is a non-invasive treatment for patients with mild and moderate Alzheimer’s Disease. which combines focused transcranial magnetic stimulation of … Continue reading →

Posted in For Doctors (mostly), For Researchers (mostly), Management of Condition, National, NIHR, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, UK | Tagged Birmingham, Cognitive Remediation Combined with Transcranial Magnetic Stimulation in Alzheimer’s Disease, Cognitive Training, Cognitive Training and rTMS in Alzheimer’s Disease, Magnetic Resonance Imaging (MRI), MRI, National Institute for Health Research (NIHR), NeuroAD™ for Mild and Moderate Alzheimer’s Disease, Neuronix (NeuroAD™ System), NIHR Horizon Scanning Centre (NIHR HSC), NIHR HSC Technology Alerts, Repetitive Transcranial Magnetic Stimulation, TMS: Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation (TMS), University of Birmingham, University of Birmingham: NIHR HSC, West Midlands | Leave a comment

Alzheimer’s Disease-Related Gray Matter Atrophy Prevention Using B-Vitamin Treatment (NHS Choices / PNAS)

Posted on June 3, 2013 by Dementia and Elderly Care News

Summary Researchers explored the prevention of brain atrophy in areas related to cognitive decline and Alzheimer’s disease (AD) by lowering elevated plasma homocysteine using B vitamins. An earlier study on people with increased dementia risk had indicated that high-dose B-vitamin … Continue reading →

Posted in For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Nutrition, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Alzheimer's Disease, Atrophy and Cognition, B vitamins (Folate B6 and B12), B-Vitamin Supplementation, B-Vitamin Treatments, Behind the Headlines, Brain Atrophy, Critical Appraisals, Diet and Alzheimer's Brain Changes, Dietary Choices, Folic Acid, Functional Magnetic Resonance Imaging of the Brain (FMRIB) Centre: University of Oxford, Gray Matter Atrophy, Homocysteine, John Radcliffe Hospital: Oxford, Magnetic Resonance Imaging (MRI), MCI, Medial Temporal Lobe, Mild Cognitive Impairment (MCI), MRI, MRI Brain Imaging, MRI Scans, Neuropsychological Tests, Nuffield Department of Clinical Neurosciences: University of Oxford, Plasma Homocysteine, PNAS, Proceedings of the National Academy of Sciences of the United States of America (PNAS), Regional Brain Atrophy, University of Oxford, Vitamin B Slows the Progression of Alzheimer’s Disease, Vitamin B12, Vitamin B6 | Leave a comment

Tag Archives: MRI

Further Dementia Diagnostic Test Accuracy Systematic Review Protocols (Cochrane Database)

Cognitive and Neuroimaging Predictors of Progression from Mild Cognitive Impairment to Dementia (NHS Choices / Journal of Alzheimer’s Disease)

Frontotemporal Dementia (BMJ)

NeuroAD™ for Mild and Moderate Alzheimer’s Disease (NIHR)

Alzheimer’s Disease-Related Gray Matter Atrophy Prevention Using B-Vitamin Treatment (NHS Choices / PNAS)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites